Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California. Show more

Location: 2451 Bert Dr., Hollister, CA, 95023, United States | Website: https://www.teknova.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare


Market Cap

257.1M

52 Wk Range

$1.23 - $10.37

Previous Close

$4.81

Open

$4.76

Volume

397,087

Day Range

$4.46 - $4.84

Enterprise Value

265.5M

Cash

26.27M

Avg Qtr Burn

-2.484M

Insider Ownership

10.95%

Institutional Own.

82.17%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date